ALZA Corp. and Marion Merrell Dow Inc. file suit against Ciba-Geigy for patent infringement.PALO ALTO, Calif.--(BUSINESS WIRE)--Jan. 25, 1995--ALZA Corp. and Marion Merrell Dow Inc. of Kansas City, Mo., today announced that they filed a lawsuit against Ciba-Geigy Corp. and LTS LTS 1 Latent tetany syndrome, see there 2. Low-threshold spike–neurology Lohmann Therapy Systems Corp. for infringement of two United States patents issued to ALZA relating to the transdermal administration of nicotine. ALZA and Marion Merrell Dow believe that these patents are infringed by the manufacture, use and sale in the United States of Ciba-Geigy's Habitrol nicotine product. The lawsuit was filed in U.S. District Court for the Southern District of New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . It requests that the court enjoin To direct, require, command, or admonish. Enjoin connotes a degree of urgency, as when a court enjoins one party in a lawsuit by ordering the person to do, or refrain from doing, something to prevent permanent loss to the other party or parties. the manufacture and sale of Habitrol and award damages. The most frequently prescribed product among the nicotine patches in the United States is Nicoderm (nicotine transdermal system nicotine transdermal system Clear Nicoderm CQ, Habitrol, Nicoderm CQ, Nicotrol, NiQuitin (UK) Pharmacologic class: Cholinergic Therapeutic class: Smoking deterrent Pregnancy risk category C ). Developed jointly by ALZA and Marion Merrell Dow and marketed by Marion Merrell Dow in the United States, Nicoderm was the first transdermal nicotine patch approved for smoking cessation smoking cessation Public health Temporary or permanent halting of habitual cigarette smoking; withdrawal therapies–eg, hypnosis, psychotherapy, group counseling, exposing smokers to Pts with terminal lung CA and nicotine chewing gum are often ineffective. therapy in the United States. The product delivers nicotine over 24 hours, thus reducing the nicotine craving many smokers experience. ALZA Corp. is a leading drug delivery systems company that develops, manufactures and markets a broad range of therapeutic systems that improve the medical and economic value of drugs. ALZA's therapeutic systems provide rate-controlled administration of medication. Marion Merrell Dow is a research-based global pharmaceutical organization dedicated to improving the longevity and quality of human life. The company is involved in the discovery, development, manufacture and sale of pharmaceutical products worldwide. CONTACT: ALZA Corp. Dawn Guthart, 415/494-5222 (Media Relations) Michael Boennighausen, 415/494-5222 (Investor Relations Investor relations The process by which the corporation communicates with its investors. ) Marion Merrell Dow Inc. Charles F. Rouse III or Richard M. Johnson, 816/966-4000 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion